Drinking in Atlantic salmon (Salmo salar) juveniles was investigated in fresh water and following transfer to sea water. There was a significant effect of fish size on drinking, and smelts (20-30 g) imbibed about ten times less water than alevins of 0.2-0.3 g. Freshwater smelts drank at a rate of 0.15 +/- 0.03 ml . kg(-1). h(-1) and administration of doses of 10 or 20 mg . k(-1) of papaverine (stimulator of the renin- angiotensin system RAS) or [Asn(1), Val(5)]-Angiotensin II (0.4 mu mol . kg(-1)) resulted in significant increases in drinking, while administration of the angiotensin converting enzyme inhibitor, enalapril (50 mg . kg(-1)) had no effect on drinking. Transfer of Atlantic salmon smelts to 1/3, 2/3 and full strength sea water resulted in significant increases in drinking to 1.06 +/- 0.12, 1.24 +/- 0.0.16 and 3.89 +/- 0.28 ml . kg(-1). h(-1), respectively. In sea water, stimulation of the endogenous RAS by administration of papaverine (20 mg . kg(-1)) resulted in a 20% increase in drinking, while administration of enalapril to doses of 50 and 200 mg . kg(-1) lowered drinking to 1.99 +/- 0.38 and 0.32 +/- 0.06 ml . kg(-1). h(-1), respectively. All treatments were without effect on blood plasma levels of Na+ and Cl- in fresh water, while in sea water smelts both stimulation and inhibition of drinking resulted in hemoconcentration of Na+ and Cl-. The role of the renin angiotensin system in control of drinking and hydromineral balance in Atlantic salmon is discussed.